Safety and efficacy of extended-duration thromboembolic prophylaxis following radical cystectomy.

Authors

null

Harras B. Zaid

Department of Urology, Mayo Clinic, Rochester, MN

Harras B. Zaid , David Yang , Matthew K. Tollefson , Igor Frank , William P. Parker , Robert Houston Thompson , R. Jeffrey Karnes , Stephen A. Boorjian

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Urothelial Carcinoma

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 389)

DOI

10.1200/jco.2016.34.2_suppl.389

Abstract #

389

Poster Bd #

G2

Abstract Disclosures

Similar Posters

Poster

2019 Genitourinary Cancers Symposium

Twenty-eight-day prophylaxis with apixaban after radical cystectomy: Early results in safety.

Twenty-eight-day prophylaxis with apixaban after radical cystectomy: Early results in safety.

First Author: Taha Anwar

Poster

2019 Gastrointestinal Cancers Symposium

The strategy of zero-mortality due to postoperative VTE in patients with colorectal cancer.

The strategy of zero-mortality due to postoperative VTE in patients with colorectal cancer.

First Author: Shoko Iwahashi

First Author: Yoon Ju Jung